ARNA - Arena Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue21,33792,16313,398
Cost of Revenue---
Gross Profit21,33792,16313,398
Operating Expenses
Research Development70,98863,78283,283
Selling General and Administrative30,34127,52930,281
Non Recurring11,9756,1153,346
Total Operating Expenses---
Operating Income or Loss-91,967-5,263-103,512
Income from Continuing Operations
Total Other Income/Expenses Net2,232-525-367
Earnings Before Interest and Taxes-89,735-5,788-103,879
Interest Expense6,1196,5126,828
Income Before Tax-95,854-12,300-110,707
Income Tax Expense---
Minority Interest-491491
Net Income From Continuing Ops-95,854-12,300-110,707
Non-recurring Events
Discontinued Operations3,122-10,5962,728
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-91,407-22,516-107,979
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-91,407-22,516-107,979